Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Fujisawa: Overseas Sales Exceed \150 Bil.
May 13, 2002
- GL Covering All Clinical Research to Be Drafted
May 13, 2002
- Daiichi Starts Research on Thrombosis Genes with Keio Univ.
May 13, 2002
- Monkasho Drafts GL on Intellectual Property Rights
May 13, 2002
- Sysmex Joins Hands with Keio Univ. for Advanced Medicine Project
May 13, 2002
- MPC Required Additional Report on Fibrinogen Product
May 13, 2002
- Nifedipine Effects Equivalent to those of ACE Inhibitors: Bayer
May 13, 2002
- Secondary Prevention Implementation Rate Needs to Be Increased: JHSF Survey
May 13, 2002
- Toxicogenomic Project Aims at Safety Prediction System
May 13, 2002
- WEBSITE NEWS
April 29, 2002
- LIFE Corporation to Expand Health Food Product Line
April 29, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
April 29, 2002
- NPO to Be Inaugurated to Promote Self-medication
April 29, 2002
- Kusuri Proverbs Reveal Japanese Spirit (8)
April 29, 2002
- Drug Terashima: Sales Up to \37,883 Mil.
April 29, 2002
- 8 NCEs Including Infliximab Included in NHI Price List
April 29, 2002
- Showa Denko Develops Anesthetic Waste Gas Disposal System
April 29, 2002
- Applicants' Sales Forecasts for New Drugs Announced by Korosho
April 29, 2002
- MEDICAL DEVICE NEWS IN BRIEF
April 29, 2002
- Korosho Invites Opinions on Its Vision from Industry
April 29, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…